MAIA Biotechnology
MAIA
21 hedge funds and large institutions have $6.09M invested in MAIA Biotechnology in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 4 closing their positions.
305% more capital invested
Capital invested by funds: $1.5M → $6.09M (+$4.59M)
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
5% more funds holding
Funds holding: 20 → 21 (+1)
4.88% more ownership
Funds ownership: 3.3% → 8.19% (+4.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HFF
Halter Ferguson Financial
Carmel,
Indiana
|
+$2.27M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$805K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$326K |
| 4 |
BlackRock
New York
|
+$194K |
| 5 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$51.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$71K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$52.2K |
| 3 |
Renaissance Technologies
New York
|
-$42K |
| 4 |
Jane Street
New York
|
-$41.4K |
| 5 |
Morgan Stanley
New York
|
-$15.8K |
MAIA Hedge Fund Activity: Q2 2024 in Review
21 of the 6,936 institutional investors tracked by Wall St. Rank reported a position in MAIA Biotechnology (MAIA) for Q2 2024, worth a combined $6.09M — up 305% from $1.5M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new MAIA positions and 4 closed out — a net gain of 1 holder — while 9 added to existing stakes and 4 trimmed.
The largest buyer was Halter Ferguson Financial, opening a new position worth an estimated $2.27M. The largest seller was Virtu Financial, exiting entirely with an estimated $71K sold.
- 21 institutional investors held MAIA Biotechnology (MAIA) as of Q2 2024, up from 20 in Q1 2024.
- Funds reported $6.09M of MAIA Biotechnology stock for Q2 2024, up 305% quarter-over-quarter.
- 5 funds opened new MAIA Biotechnology positions in Q2 2024 and 4 closed out, a net change of +1 holder.
- The largest MAIA Biotechnology buyer in Q2 2024 was Halter Ferguson Financial, an estimated $2.27M added.
- The largest MAIA Biotechnology seller in Q2 2024 was Virtu Financial, an estimated $71K sold.
Based on aggregated 13F filings for Q2 2024.